Anne Nunes

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANIK alerts

About Anne Nunes

Anne Nunes is recorded as COO at Anika Therapeutics, Inc. (ANIK) since June 19, 2023. Anika Therapeutics, Inc. reported in an 8-K filed June 21, 2023 that Anne Nunes was appointed Senior Vice President, Chief Operations Officer, effective June 19, 2023. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.

“On June 14, 2023, the Board appointed Anne Nunes, age 54, as the Company’s Senior Vice President, Chief Operations Officer, effective as of June 19, 2023.”

Anika Therapeutics, Inc. Form 8-K, filed June 21, 2023 · Read the filing

Affiliation history

Anika Therapeutics, Inc. (ANIK)
COO

SEC 8-K

Current
2023-06-19–present

Company network

Anika Therapeutics, Inc.

ANIK

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

COO

2023-06-19–present

Leadership on record at Anika Therapeutics, Inc.

Cheryl Blanchard CEO, Board Member
Stephen (Steve) Griffin CEO, Board Member
Stephen D. Griffin CEO, CFO, Board Member
Steve Griffin CEO, Board Member
Cheryl R. Blanchard Chairman, Board Member
Jeffery S. Thompson Chairman
John B. Henneman, III Chairman, Board Member
Michael Levitz CFO
Stephen Griffin CFO
David B. Colleran General Counsel

Recent activity

Executive change Appointed: Senior Vice President, Chief Operations Officer Anika Therapeutics, Inc. (ANIK)
2023-06-19